RT @PotreroMedical: As a physician how do you get into the exciting world of startups & innovation? We invited @lancemblack on the podcast…

RT @LuminareInc: Luminare Partners With the City of Corpus Christi To Deploy Innoculate™ - A COVID-19 Vaccine Management Solution https://t…

TMCx alum and Biobridge company, Neurescue, aims to bring the survival rate of cardiac arrest to 9 out of 10 people with its new device under #FDA review. https://t.co/VQtjsfAq1h @CNBC @FDADeviceInfo @US_FDA

TMCx alum @StradosLabs reaches regulatory milestone https://t.co/YBQPBaOwbq

TMCx alum Strados announces FDA clearance https://t.co/O78D3YYJsV

TMCx alum Oncora announces a new partnership https://t.co/Ds1dCBdZLC

RT @TXMedCenter: Physician, astronaut and venture capitalist Dr. Bernard A. Harris Jr. was appointed vice chair of the Texas Medical Center…

TMC Biodesign alum VastBiome share their recent seed raise. https://t.co/aYCUW6CHft

TMCx alumni @virtilabs was named one of Time's 100 Best Inventions of 2020 for their contributions to scaling medical education and training. The UK-based company has a strong Houston and TMC presence. https://t.co/vGEV122tIg https://t.co/aSs4GqTkmm

Meet the newest TMCx companies who are building relationships with our members and partners: https://t.co/nheFRsz80w https://t.co/oLlCIeefbe

TMCx08 company BetterConsult has partnered with Outcome Health to enable more clinicians to access the pre-consultation tool that make patient visits more intentional and reduce documentation burden. https://t.co/raFgbEbdAS

RT @TXMedCenter: Thanksgiving is a time of gathering with family and friends, but this year will be different. If you want to be safe, cele…

TMC Venture Fund portfolio company @medableinc has driven tremendous growth in 2020 and raised $91M this week. https://t.co/I2ClcNaRs2

TMC #Biodesign alum VastBiome, a drug discovery company that finds biomarkers and therapies to treat cancer and autoimmune disease, closed a $4.5M seed fund. https://t.co/7mRk0sJcXA @VastBiome #Innovation #drugdiscovery #cancertherapy

@Allotrope_Med (TMCx3) announces FDA clearance of StimSite™ https://t.co/MjbcW4Bch1

TMC Innovation has awarded a prize from #TMCVentureFund to OncoRes, an Australian based #medicaldevice company. They have gained automatic entry into our next TMCx bootcamp and an investment! https://t.co/RpYNqg1VZl @InnoMapHou

RT @TXMedCenter: We are excited with the continued turnout of the TMC polling location, with over 11,100 people safely voting on our campus…

#TMCx Spring 2020 company @WeAreLantum has partnered with the UK’s National Health Service (NHS) to provide solutions that ensure sufficient #COVID19 surge capacity. #DigitalHealth #Innovation @AccentureHealth @Accenture https://t.co/xSBbAmMpra

RT @TMCCEOMcKeon: Two former TMCx companies featured in @USAToday for their extensive work in #COVID19 widespread testing. https://t.co/mvS…

Did you miss the TMC ACT Application deadline? Connect with our team to learn more about our application process and program! https://t.co/VPsIQZpNER https://t.co/ownnvQ3Xvk

RT @admetsys: Admetsys Secures CE Mark Approval for PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System 👏👏👏👏 https:/…

Don't forget that TMC has an early voting location this year! TMC will be hosting early voting October 13-30. To learn more and view all voting locations, visit https://t.co/dYSYruXc6T. #TMCVotes #HarrisVotes Check the schedule below to #vote. https://t.co/AtLBLNcCqv

Two former TMCx companies featured in @USAToday for their extensive work on #COVID19 widespread testing. https://t.co/b31N70eyFk https://t.co/EeydDxLy8m

In-person early voting for the fall election begins on our campus today and continues through Friday, October 30! Remember to bring an approved form of identification. #TMCVotes #HarrisVotes #MaskUp #Vote #2020Election

Applications for TMC ACT are now closed. We are looking forward to reviewing applications and selecting the companies that will join us here in #Houston. Stay informed about #TMC ACT by visiting our website: https://t.co/eqCvGeoHJE https://t.co/ELNMzr28TT

In-person early voting for the #2020Elections will be available for the first time ever on the @TXMedCenter campus at the JP McGovern Commons. Check the schedule and join us to #vote! #HarrisVotes #TMCVotes https://t.co/dsnijqBfxi https://t.co/FoJUUMHxkt

The TMC ACT deadline is TOMORROW! Don’t miss this unique opportunity to participate in this CPRIT funded accelerator for cancer therapeutics. https://t.co/eqCvGeoHJE https://t.co/LBi3y6HygK

Congratulations, @rhaeos! Anna Lisa and team are great members of our community at TMC Innovation. https://t.co/BRcALWVMeN

RT @WestwoodLA: Which London companies want to access the World’s biggest medical center, the @TXMedCenter? Great opportunity to do so, fro…

5 days left to apply to the #TMC ACT program! Make sure to submit your applications by this Friday, October 9. Our team hopes you will join us in #Houston. https://t.co/eqCvGeoHJE https://t.co/zxvNfHMktj

Join us in welcoming 21 startups to TMCx Bootcamp next week! https://t.co/jYJ50quLEn

The TMC ACT program has extended its application deadline until Friday, October 9. If you are a Texas-based cancer therapeutic entrepreneur, you still have time to join our nine-month program in #Houston. https://t.co/eqCvGeoHJE https://t.co/pJQgpHfMz7

.@GaussSurgical, a company from our first #TMCx cohort, has partnered with Cellex, a leader in point-of-care diagnostic testing, to develop and launch the first-ever rapid, at-home #COVID19 antigen test and mobile app. https://t.co/y8WZCgJPyl #BardaDrive #TexasMedicalCenter

RT @GaussSurgical: In case you missed it, check out CEO Siddarth Satish on CNBC discussing our partnership with Cellex to develop the first…

The deadline to apply to TMC’s ACT program is this week! If you are a biotech entrepreneuror researcher contemplating translational development, apply by Sept. 30. https://t.co/eqCvGeoHJE https://t.co/t1pgbFDIy3

RT @TXMedCenter: There is still time to sign up for our golf tournament! Join us at Champions Golf Club on October 13. Proceeds from the e…

Making its first presence in Houston, TMC ACT program is a CPRIT funded accelerator launched in collaboration with the Gulf Coast Consortium and @utmbhealth. TMC ACT is currently taking applications until Sept. 30 for startups. https://t.co/eqCvGeoHJE https://t.co/3qdh2dq1n7

RT @dreamit: Dreamit Healthtech MD @AdamDakin will be speaking tomorrow on a @thoughtbot Digital Health Innovation panel with @TMCInnovatio…

RT @ZibrioBalance: It's the first day of fall, and National Fall Prevention day. Learn the latest in #fallprevention and #seniorfitness at…

TMC’s #ACT program is a nine-month program designed to enhance oncology biotech entrepreneurship training and drug development programs in Texas. Application deadline is Sept. 30. Learn more and apply: https://t.co/eqCvGeoHJE https://t.co/BJ5MHHGGqX

Calling all Texas-based cancer therapeutic entrepreneurs! TMC #ACT is recruiting companies to join us at TMC Innovation for a 9-month program designed to enhance oncology biotech and drug development in Texas. https://t.co/eqCvGeoHJE https://t.co/KlzwtgyBiv

RT @thoughtbot: Join program leaders from Texas Medical Center Innovation, Digital Health Institute for Transformation, Dreamit Healthtech…

Say ‘Thank You’ to our local schools, teachers, families and students! Donate to 3 local school’s @amazon wish list to help those impacted by #COVID19 with a donation of supplies. #ClearTheList #ClearTheLists #SupportTeachers https://t.co/FBYvtqba6y https://t.co/aI3lFDz7AY

Our program, TMC ACT (Accelerator for Cancer Therapeutics), aims to provide training, resources and mentoring to Texas inventors and startups looking to bring novel #cancer therapies from early drug discovery to commercialization. @CPRITTexas @utmbhealth https://t.co/pqkFDWpGdg https://t.co/kWOlUgqCVQ

Prolonged confinement of long-duration spaceflight is akin to the COVID-19 pandemic social and physical distancing. Leaders form #TMC and #Australia share how the space sector may provide learning for us here on Earth.@LanceBlack @HarrisAEyre #TMCBiobridge https://t.co/n30kXebkx6

We are about to begin our conversation about building innovation partnerships with an esteemed panel. Join us: https://t.co/TvMo82davI with @UMassM2D2 and @BARDA https://t.co/ZUUfDdNWFX

Join us to discuss the step-by-step considerations when designing an early stage drug molecule led by our TMC ACT Team on August 27th. https://t.co/d6cUsqRhU6

We can't wait for tomorrow- join us and @NCIsbir at 1pm central! https://t.co/0colxYadHN